CellBion Rises as Leading RPT Stock·HLB Group’s 11 Stocks Decline[K-Bio Pulse]
created on 03/14/2025 7:58:03 AM
Unauthorized reproduction or distribution is illegal and subject to criminal penalties.
Pharm Edaily enforces a zero-tolerance policy and will take strict action.
Pharm Edaily enforces a zero-tolerance policy and will take strict action.
Premium Content
이 기사는 유료 구독자를 위한 프리미엄 콘텐츠입니다.
유료 구독(플래티넘)을 통해 더 많은 콘텐츠를 만나보세요.
This article is premium content for paid subscribers.
Subscribe to paid subscription (Platinum) for full access.
나은경 기자 eeee@edaily.co.kr
함께보면 좋은 뉴스
![CellBion Rises as Leading RPT Stock·HLB Group’s 11 Stocks Decline[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031400303b.jpg)
![글로벌 생태계에 녹아들자[바이오, 해외에 답 있다]⑤](https://image.edaily.co.kr/images/vision/files/NP/S/2025/02/PS25022600610b.jpg)
![中·美 진출 기대감에 대화제약·애니젠 上…악성 루머에 시달린 HLB그룹株[바이오맥짚기]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031100268b.jpg)
